Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00692419 · ClinicalTrials.gov registry record · NA
Pain, Sexual Dysfunction, and Depression in Hemodialysis Patients
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 315
- Enrollment target
NCT00692419: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT00692419 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 315 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00692419, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 315 participants
- Enrollment target
Study Summary
This study is seeking to identify the most effective strategy to manage pain, sexual dysfunction, and depression in patients receiving chronic hemodialysis therapy.
Primary Outcome
The primary outcome of this study is the change in symptom scores during the intervention phase of the study
Interventions
- BEHAVIORAL Symptom management nurse intervention
- BEHAVIORAL Feedback intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT00692419 record still lists
NCT00692419 is an interventional study that assigns participants to a tested intervention. The registered 315 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 2 interventions - of which Symptom management nurse intervention is the first listed.
NCT00692419 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00692419 about?
NCT00692419 is a clinical study titled "Pain, Sexual Dysfunction, and Depression in Hemodialysis Patients". This study is seeking to identify the most effective strategy to manage pain, sexual dysfunction, and depression in patients receiving chronic hemodialysis therapy.
What is the current status of trial NCT00692419?
This trial is currently completed. It is a NA study. The enrollment target is 315 participants. The study started on 2008-11. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00692419?
The interventions under investigation include: Symptom management nurse intervention (BEHAVIORAL), Feedback intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00692419?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00692419's enrollment target sits among peer trials
315 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04812366 · 315 participants · Phase 2
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- NCT05101460 · 315 participants
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
- NCT05897320 · 315 participants · Phase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- NCT06439082 · 315 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia